Home / Pharma Healthcare / United States Immunotherapy Drugs Market Report 2016

United States Immunotherapy Drugs Market Report 2016

  • Id : RNR-53291
  • Category : Pharma Healthcare
  • Publish Date : Jan 2017
  • Pages : 118
  • Format : PDF
License Type

Description
Sales, means the sales volume of Immunotherapy Drugs
Revenue, means the sales value of Immunotherapy Drugs

This report studies sales (consumption) of Immunotherapy Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Merck-Pfizer
    Eli Lilly
    Amgen
    Roche
    Bristol Myers Squibb
    Dendreon (Valeant)
    Novartis
    Seattle Genetics
    Celgene
    AstraZeneca
    Northwest Biotherapeutics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Specific Cancer Immunotherapy Drugs
    Non-Specific Cancer Immunotherapy Drugs
    Type III
Split by applications, this report focuses on sales, market share and growth rate of  Immunotherapy Drugs in each application, can be divided into
    Leukemia Treatment
    Colorectal Cancer Treatment
    Other Cancer Treatment